1H MR spectroscopy using TE averaged PRESS: A more sensitive technique to detect neurodegeneration associated with Alzheimer's disease
Open Access
- 29 March 2005
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 53 (4) , 777-782
- https://doi.org/10.1002/mrm.20419
Abstract
A sensitive proton magnetic resonance spectroscopy (1H MRS) acquisition scheme that is capable of discriminating between normal controls and a group of patients with early Alzheimer's disease (AD) is presented. The performance of this newly developed method, TE averaged PRESS (PRESS-J), in detecting neurodegeneration associated with early AD is compared with that of short echo time (TE) PRESS. A stepwise discriminant function analysis is used to construct discriminant functions for both pulse sequences. These functions are each composed of a single predictor: the N-acetyl aspartate (NAA)/creatine (Cr) ratio for PRESS-J, and the NAA/myoInositol (mI) ratio for PRESS. We observed lower P-values, higher areas under the receiver operating characteristic curves, and higher sensitivity at a given specificity for the PRESS-J discriminating function in comparison with the PRESS discriminating function. The higher sensitivity of PRESS-J is due to decreased variability when the singlets are fit in the spectra. This increased sensitivity enables new MR applications and, among other benefits, allows for smaller group sizes in drug trials, which can significantly reduce the cost of such trials. Magn Reson Med 53:777–782, 2005.Keywords
This publication has 18 references indexed in Scilit:
- Cognitive impairment: classification by 1H magnetic resonance spectroscopyEuropean Journal of Neurology, 2004
- Measurement of brain glutamate using TE‐averaged PRESS at 3TMagnetic Resonance in Medicine, 2004
- Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s DiseaseAmerican Journal of Psychiatry, 2003
- Proton NMR chemical shifts and coupling constants for brain metabolitesNMR in Biomedicine, 2000
- Multi-modal volume registration by maximization of mutual informationMedical Image Analysis, 1996
- Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's diseaseMagnetic Resonance Imaging, 1995
- Abnormal cerebral metabolite concentrations in patients with probable alzheimer diseaseMagnetic Resonance in Medicine, 1994
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984